Boston Scientific Corp
BSX102.840USD
+0.100+0.10%
Cierre 04/30, 16:00（ET）Cotizaciones retrasadas 15 min
151.64BCap. mercado
81.84P/E TTM
Más Datos de Boston Scientific Corp Compañía
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.
Información de la empresa
Código de la empresaBSX
Nombre de la empresaBoston Scientific Corp
Fecha de salida a bolsaMay 19, 1992
Fundada en1979
Director ejecutivoMr. Michael F. (Mike) Mahoney
Número de empleados53000
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 19
Dirección300 Boston Scientific Way
CiudadMARLBOROUGH
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal01752-1234
Teléfono15086834000
Sitio Webhttps://www.bostonscientific.com/en-US/Home.html
Código de la empresaBSX
Fecha de salida a bolsaMay 19, 1992
Fundada en1979
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.87M
-3.05%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
62.90K
--
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
52.64K
--
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
36.19K
-11.77%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
34.94K
--
Mr. David C. Habiger
Mr. David C. Habiger
Independent Director
Independent Director
3.55K
--
Mr. Yoshiaki Fujimori
Mr. Yoshiaki Fujimori
Independent Director
Independent Director
2.90K
--
Mr. Arthur Crosswell Butcher
Mr. Arthur Crosswell Butcher
Executive Vice President, Group President, MedSurg and Asia Pacific
Executive Vice President, Group President, MedSurg and Asia Pacific
--
--
Mr. Edward J. Ludwig
Mr. Edward J. Ludwig
Lead Independent Director
Lead Independent Director
--
--
Ms. Meghan Scanlon
Ms. Meghan Scanlon
Senior Vice President and President - Urology
Senior Vice President and President - Urology
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.87M
-3.05%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
62.90K
--
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
52.64K
--
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
36.19K
-11.77%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
34.94K
--
Mr. David C. Habiger
Mr. David C. Habiger
Independent Director
Independent Director
3.55K
--
Desglose de ingresos
Divisa: USDHora de actualización: dom., 6 de abr
Divisa: USDHora de actualización: dom., 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Endoscopy
2.69B
16.04%
Interventional Cardiology Therapies
2.65B
15.79%
Peripheral Interventions
2.41B
14.39%
Cardiac Rhythm Management
2.28B
13.61%
Urology
2.20B
13.14%
Other
4.53B
27.03%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
10.21B
60.97%
EMEA (Europe, Middle East and Africa)
3.23B
19.28%
Asia Pacific
2.69B
16.04%
Latin America and Canada
624.00M
3.73%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Endoscopy
2.69B
16.04%
Interventional Cardiology Therapies
2.65B
15.79%
Peripheral Interventions
2.41B
14.39%
Cardiac Rhythm Management
2.28B
13.61%
Urology
2.20B
13.14%
Other
4.53B
27.03%
Accionista
Hora de actualización: vie., 21 de feb
Hora de actualización: vie., 21 de feb
Estadísticas de accionistas
Tipo
Estadísticas de accionistas
Accionista
Proporción
The Vanguard Group, Inc.
8.94%
Fidelity Management & Research Company LLC
8.19%
BlackRock Institutional Trust Company, N.A.
5.19%
State Street Global Advisors (US)
4.32%
PRIMECAP Management Company
2.50%
Other
70.86%
Estadísticas de accionistas
Accionista
Proporción
The Vanguard Group, Inc.
8.94%
Fidelity Management & Research Company LLC
8.19%
BlackRock Institutional Trust Company, N.A.
5.19%
State Street Global Advisors (US)
4.32%
PRIMECAP Management Company
2.50%
Other
70.86%
Tipo
Accionista
Proporción
Investment Advisor
43.37%
Investment Advisor/Hedge Fund
37.16%
Hedge Fund
3.29%
Pension Fund
2.97%
Research Firm
2.42%
Bank and Trust
1.65%
Sovereign Wealth Fund
1.47%
Private Equity
0.21%
Insurance Company
0.21%
Other
7.26%
Participación institucional
Hora de actualización: dom., 19 de ene
Hora de actualización: dom., 19 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q1
2612
1.38B
93.37%
+6.11M
2024Q4
2559
1.38B
93.61%
+1.09M
2024Q3
2417
1.37B
92.76%
-24.32M
2024Q2
2341
1.37B
93.29%
-18.17M
2024Q1
2227
1.37B
93.23%
-40.14M
2023Q4
2171
1.39B
94.95%
-25.34M
2023Q3
2110
1.39B
95.17%
-6.29M
2023Q2
2081
1.38B
95.67%
-15.63M
2023Q1
2012
1.36B
94.85%
-23.81M
2022Q4
1993
1.36B
94.66%
-54.91M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
132.25M
8.94%
+1.62M
+1.24%
Dec 31, 2024
Fidelity Management & Research Company LLC
121.20M
8.19%
-2.05M
-1.66%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
76.72M
5.19%
+7.50M
+10.84%
Dec 31, 2024
State Street Global Advisors (US)
63.96M
4.32%
+1.12M
+1.78%
Dec 31, 2024
PRIMECAP Management Company
36.93M
2.5%
-896.83K
-2.37%
Dec 31, 2024
Wellington Management Company, LLP
36.17M
2.45%
+3.34M
+10.19%
Dec 31, 2024
Geode Capital Management, L.L.C.
30.63M
2.07%
+1.04M
+3.52%
Dec 31, 2024
Capital World Investors
27.90M
1.89%
+6.22M
+28.67%
Dec 31, 2024
The Bollard Group, LLC
20.73M
1.4%
-510.32K
-2.40%
Dec 31, 2024
BlackRock Investment Management (UK) Ltd.
20.37M
1.38%
+757.90K
+3.86%
Dec 31, 2024
Ver más
ETFs relacionados
Hora de actualización: dom., 6 de abr
Hora de actualización: dom., 6 de abr
Nombre
Proporción
iShares U.S. Medical Devices ETF
10.77%
Goldman Sachs Future Health Care Equity ETF
8.56%
iShares Health Innovation Active ETF
5.12%
NYLI Healthy Hearts ETF
4.83%
JPMorgan Healthcare Leaders ETF
4.25%
Global X Aging Population ETF
3.98%
Hennessy Stance ESG ETF
3.4%
FT Raymond James Multicap Growth Equity ETF
2.84%
Tema Cardiovascular and Metabolic ETF
2.83%
iShares US Thematic Rotation Active ETF
2.82%
Ver más
iShares U.S. Medical Devices ETF
Proporción10.77%
Goldman Sachs Future Health Care Equity ETF
Proporción8.56%
iShares Health Innovation Active ETF
Proporción5.12%
NYLI Healthy Hearts ETF
Proporción4.83%
JPMorgan Healthcare Leaders ETF
Proporción4.25%
Global X Aging Population ETF
Proporción3.98%
Hennessy Stance ESG ETF
Proporción3.4%
FT Raymond James Multicap Growth Equity ETF
Proporción2.84%
Tema Cardiovascular and Metabolic ETF
Proporción2.83%
iShares US Thematic Rotation Active ETF
Proporción2.82%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos